Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Entecavir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Entecavir 500microgram tablets
0503031B0AAAAAA
|
Entecavir | Entecavir | Infections | 633 |
|
Entecavir 1mg tablets
0503031B0AAABAB
|
Entecavir | Entecavir | Infections | 25 |
|
Baraclude 0.5mg tablets
0503031B0BBAAAA
|
Baraclude | Entecavir | Infections | 22 |
|
Entecavir 50micrograms/ml oral solution sugar free
0503031B0AAACAC
|
Entecavir | Entecavir | Infections | 7 |
|
Baraclude 0.05mg/ml oral solution
0503031B0BBACAC
|
Baraclude | Entecavir | Infections | 4 |
|
Baraclude 1mg tablets
0503031B0BBABAB
|
Baraclude | Entecavir | Infections | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.